A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps

BACKGROUND: Topical intranasal corticosteroid sprays (INCSs) are standard treatment for nasal polyps (NPs), but their efficacy is reduced by poor patient compliance and impaired access of drug to the sinus mucosa. A corticosteroid‐eluting sinus implant was designed to address these limitations in pa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int Forum Allergy Rhinol
Autori principali: Kern, Robert C., Stolovitzky, J. Pablo, Silvers, Stacey L., Singh, Ameet, Lee, Jivianne T., Yen, David M., Iloreta, Alfred M.C., Langford, Francis P.J., Karanfilov, Boris, Matheny, Keith E., Stambaugh, James W., Gawlicka, Anna K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5900893/
https://ncbi.nlm.nih.gov/pubmed/29350840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alr.22084
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi